Bovie Medical Corporation (NYSEMKT:BVX) Can’t Be Less Risky. Short Interest Decreased

September 17, 2017 - By Winifred Garcia

 Bovie Medical Corporation (NYSEMKT:BVX) Can't Be Less Risky. Short Interest Decreased

Investors sentiment decreased to 1.53 in Q4 2016. Its down 0.91, from 2.44 in 2016Q3. It worsened, as 9 investors sold Bovie Medical Corporation shares while 6 reduced holdings. 11 funds opened positions while 12 raised stakes. 9.00 million shares or 42.24% more from 6.33 million shares in 2016Q3 were reported.
Oberweis Asset Management holds 65,000 shares or 0.07% of its portfolio. Northern, Illinois-based fund reported 88,338 shares. Blackrock Institutional Tru Communication Na holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 7,897 shares. Geode Cap Mngmt Ltd Liability Company reported 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). National Bank & Trust Of America Corporation De has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Morgan Stanley holds 0% or 13,781 shares in its portfolio. Manatuck Hill Ptnrs Ltd Liability Com has invested 0.22% in Bovie Medical Corporation (NYSEMKT:BVX). Perkins Cap Inc accumulated 632,035 shares. Susquehanna Intll Gru Llp reported 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). 10,700 are owned by Commonwealth Equity Services. Globeflex Capital L P holds 0% or 200 shares in its portfolio. 5,428 are held by Deutsche Commercial Bank Ag. Moreover, Driehaus Management Lc has 0.07% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 521,516 shares. Moreover, Pura Vida Invs Ltd has 0.16% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 123,000 shares. Wasatch Inc reported 200,000 shares stake.

The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered a decrease of 9.8% in short interest. BVX’s total short interest was 129,800 shares in September as published by FINRA. Its down 9.8% from 143,900 shares, reported previously. With 101,500 shares average volume, it will take short sellers 1 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 0.56%.

The stock increased 10.53% or $0.3 on September 15, reaching $3.15. About 257,813 shares traded or 25.30% up from the average. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since September 17, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $97.21 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Businesswire.com which released: “Bovie Medical Receives 510K Clearance for Its Cool-Coagâ„¢ Generator and Open …” on March 27, 2017, also Streetinsider.com with their article: “Form 8-K BOVIE MEDICAL Corp For: Sep 15” published on September 15, 2017, Seekingalpha.com published: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” on March 10, 2017. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Businesswire.com and their article: “Bovie Medical Corporation Reports Second Quarter 2017 Financial Results and …” published on August 02, 2017 as well as Businesswire.com‘s news article titled: “Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXactâ„¢” with publication date: January 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.